Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25
$ZBIO Zenas BioPharma, Inc. (ZBIO) reported Q4 2025 GAAP loss of $4.54 per share, missing analysts’ estimates. The company did ...
$ZBIO Zenas BioPharma, Inc. (ZBIO) reported Q4 2025 GAAP loss of $4.54 per share, missing analysts’ estimates. The company did ...
For years, politicians across the Western world have insisted that windmills and solar panels would power the future while reliable ...
The Reserve Bank of India stepped up its government bond purchases from the secondary market to a record level in ...
Bank Leumi (TASE: LUMI), led by CEO Hanan Friedman, today p Source link
(This is the Warren Buffett Watch newsletter, news and analysis on all things Warren Buffett and Berkshire Hathaway. You can ...
Balchem Corporation (NASDAQ: BCPC) reported record financial results for both the fourth quarter and the full fiscal year 2025, supported ...
We believe everyone should be able to make financial decisions with confidence. While we don't cover every company or financial ...
Shares of cbdMD, Inc. (NYSE YCBD) rose 10.72% to $0.78 in Tuesday afternoon trading following the release of its fiscal ...
Moderna, Inc. (NASDAQ: MRNA) has reported a narrower net loss for the fourth quarter of fiscal 2025, when the ...
Anupam Rasayan India on Saturday reported a 12 per cent increase in consolidated net profit to Rs 61 crore for ...
Copyright © 2022-2024
All Rights Reserved
See articles for original source and related links to external sites.
Copyright © 2022-2024
All Rights Reserved
See articles for original source and related links to external sites.